GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (OTCPK:AVHHL) » Definitions » Gross Profit

AVITA Medical (AVITA Medical) Gross Profit : $43.07 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Gross Profit?

AVITA Medical's gross profit for the three months ended in Mar. 2024 was $9.59 Mil. AVITA Medical's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $43.07 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. AVITA Medical's gross profit for the three months ended in Mar. 2024 was $9.59 Mil. AVITA Medical's Revenue for the three months ended in Mar. 2024 was $11.10 Mil. Therefore, AVITA Medical's Gross Margin % for the quarter that ended in Mar. 2024 was 86.37%.

AVITA Medical had a gross margin of 86.37% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of AVITA Medical was 84.96%. The lowest was 41.23%. And the median was 75.90%.


AVITA Medical Gross Profit Historical Data

The historical data trend for AVITA Medical's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Gross Profit Chart

AVITA Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.20 11.29 23.28 28.38 42.36

AVITA Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.88 9.55 11.53 12.40 9.59

Competitive Comparison of AVITA Medical's Gross Profit

For the Medical Devices subindustry, AVITA Medical's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AVITA Medical's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's Gross Profit distribution charts can be found below:

* The bar in red indicates where AVITA Medical's Gross Profit falls into.



AVITA Medical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

AVITA Medical's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=50.143 - 7.78
=42.36

AVITA Medical's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=11.104 - 1.513
=9.59

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $43.07 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

AVITA Medical's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=9.59 / 11.104
=86.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


AVITA Medical  (OTCPK:AVHHL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

AVITA Medical had a gross margin of 86.37% for the quarter that ended in Mar. 2024 => Durable competitive advantage


AVITA Medical Gross Profit Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


AVITA Medical (AVITA Medical) Business Description

Traded in Other Exchanges
Address
28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

AVITA Medical (AVITA Medical) Headlines